Parallax Volatility Advisers’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Parallax Volatility Advisers’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,000	Closed	-$70K	–	5868
2015 Q1	$70K	Sell	2,000 -4,000	-67%	-$135K	﹤0.01%	2780
2014 Q4	$193K	Sell	6,000 -1,200	-17%	-$34.7K	﹤0.01%	2875
2014 Q3	$202K	Buy	7,200 +5,200	+260%	+$158K	﹤0.01%	2459
2014 Q2	$60K	Buy	2,000 +700	+54%	+$19.3K	﹤0.01%	2841
2014 Q1	$36K	Sell	1,300 -100	-7%	-$2.62K	﹤0.01%	2508
2013 Q4	$36K	Sell	1,400 -100	-7%	-$3.08K	﹤0.01%	2410
2013 Q3	$45K	Buy	1,500 +500	+50%	+$13.9K	﹤0.01%	1867
2013 Q2	$29K	Buy	+1,000	New	+$27.6K	﹤0.01%	1843

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Parallax Volatility Advisers's BRLI Position: Q1 2014 in Review

Parallax Volatility Advisers sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2014, closing a stake of 63 shares — an estimated $1.65K sold.

Parallax Volatility Advisers first reported a position in BRLI in Q2 2013 and held it in 3 quarters. The position peaked at $23K in Q3 2013. 162 funds tracked by Wall St. Rank hold BRLI as of Q1 2014.

Parallax Volatility Advisers reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2014 after selling out during the quarter.
Parallax Volatility Advisers sold 63 BIO-REFERENCE LABS INC-NEW- shares in Q1 2014, an estimated $1.65K.
Parallax Volatility Advisers first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 3 quarters.
Parallax Volatility Advisers's BIO-REFERENCE LABS INC-NEW- position peaked at $23K in Q3 2013.
162 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2014.

Based on Parallax Volatility Advisers's 13F filing for Q1 2014, filed 15 May 2014.